Literature DB >> 11673534

The vesicular stomatitis virus matrix protein inhibits glycoprotein 130-dependent STAT activation.

L Terstegen1, P Gatsios, S Ludwig, S Pleschka, W Jahnen-Dechent, P C Heinrich, L Graeve.   

Abstract

Infection of cells by vesicular stomatitis virus (VSV) results in the inhibition of host transcription. We show in this study that infection of HeLa cells with VSV leads to a strongly diminished activation of STAT3 and STAT1 by the inflammatory cytokine IL-6. This effect was mimicked by forced expression of a single viral protein, the matrix (M)-protein of VSV, which blocked STAT activation via chimeric receptors containing the cytoplasmic domain of the IL-6 signal transducer gp130. Western blot analysis revealed that VSV M-protein did not inhibit the nuclear translocation of activated STAT3 but did inhibit its tyrosine phosphorylation. Inhibition of STAT activation was not dependent on tyrosine 759 of the IL-6 signal transducer gp130, suggesting that the inhibitory action of VSV M-protein is not mediated by the induction of the suppressor of cytokine signaling 3. VSV M-protein inhibited gene transcription from cotransfected alpha(2)-macroglobulin or antichymotrypsin promoter/luciferase reporter constructs which contain STAT3-binding sites. However, transcription from a STAT5-dependent construct was not negatively affected. In conclusion, our data suggest that infection by VSV and specifically overexpression of the viral M-protein interferes with an important signaling pathway necessary for triggering antiviral and inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11673534     DOI: 10.4049/jimmunol.167.9.5209

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  GRIM-19, a death-regulatory gene product, suppresses Stat3 activity via functional interaction.

Authors:  Chengchen Lufei; Jing Ma; Guochang Huang; Tong Zhang; Veronica Novotny-Diermayr; Chin Thing Ong; Xinmin Cao
Journal:  EMBO J       Date:  2003-03-17       Impact factor: 11.598

2.  Identification of genetically modified Maraba virus as an oncolytic rhabdovirus.

Authors:  Jan Brun; Dan McManus; Charles Lefebvre; Kang Hu; Theresa Falls; Harold Atkins; John C Bell; J Andrea McCart; Douglas Mahoney; David F Stojdl
Journal:  Mol Ther       Date:  2010-06-15       Impact factor: 11.454

3.  A novel viral SOCS from infectious spleen and kidney necrosis virus: interacts with Jak1 and inhibits IFN-α induced Stat1/3 activation.

Authors:  Chang-Jun Guo; Li-Shi Yang; Ying-Fen Zhang; Yan-Yan Wu; Shao-Ping Weng; Xiao-Qiang Yu; Jian-Guo He
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

Review 4.  Long Non-coding RNAs: Regulators of Viral Infection and the Interferon Antiviral Response.

Authors:  Lipeng Qiu; Tao Wang; Qi Tang; Guohui Li; Peng Wu; Keping Chen
Journal:  Front Microbiol       Date:  2018-07-19       Impact factor: 5.640

Review 5.  Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy.

Authors:  Bin Zhang; Ping Cheng
Journal:  Mol Cancer       Date:  2020-11-10       Impact factor: 27.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.